Search
for
Sort by
Research 91–120 of 1000+
- Journal of Population Therapeutics and Clinical Pharmacology
- Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. Diagnosis and severity assessment
- Les Rencontres d’Experts du Psoriasis : des recommandations pour la pratique quotidienne
- Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study
- Is thyroid dysfunction a common cause of telogen effluvium?: A retrospective study
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- Efficacy of systemic minoxidil and tofacitinib combination in treatment‐resistant alopecia universalis
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- BH31 Dermoscopic analysis of patients with and without poor prognostic indicators in alopecia areata: a comparative study
- Baricitinib maintains regrowth of hair, eyebrows, and eyelashes over 3 years
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Study on Serum Vitamin D in Alopecia Areata Patients
- Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience
- Evaluation of association of vitamin D in alopecia areata: A case–control study of 100 patients in a tertiary rural hospital of Southern India
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review
- Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis
- Janus Kinase Inhibitors for Alopecia Areata
- Dietary Habits in Japanese Patients with Alopecia Areata
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Reply to: “Serum vitamin D level and disease severity of alopecia areata: A meta-regression analysis”
- Dermoscopic Analysis of Patients with and without Poor Prognostic Indicators in Alopecia Areata – A Comparative Study
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- Distribution of SALT Scores with Ritlecitinib Treatment up to 24 months from the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata
- Alopecia areata: Ritlecitinib generates substantial re-growth of scalp hair
- Review of Baricitinib in the Treatment of Alopecia Areata.
- Breakdown of Immune Tolerance in AIRE-Deficient Rats Induces a Severe Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy–like Autoimmune Disease
- A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants